: Peptides like BPC-157 and TB-500 can be game-changers, but your journey will be your own
TB4 has been investigated for wound healing, muscle and cardiac repair, and eye injuries, though human evidence remains limited and long-term safety in humans is not well established
Signs suggesting adequate treatment include plateau in improvement for two or more weeks, significant resolution of primary concerns, and strong improvement maintained during previous breaks
Systematic reviews identify 36 studies demonstrating that BPC-157 improves functional, structural, and biomechanical outcomes across muscle, tendon, ligament, and bone injuries in preclinical models, with the peptide enhancing collagen synthesis, improving tensile strength, and accelerating cellular proliferation in tendon fibroblasts through FAK-paxillin pathway activation critical for cellular adhesion, migration, proliferation, and survival
Oral BPC-157 is often chosen because it is easy to take daily and may offer targeted support for the gut and digestive system, while still providing overall systemic recovery support